Cell Image 1

Discovering the
future of medicine

Wistar Science: Bold. Imaginative. Inspired.

Learn More

Recent Press Releases

View all ›

Engineered DNA-encoded PCSK9 Inhibitors May Provide an Effective Alternative for Treating High Cholesterol 

Synthetic DNA-delivered Antibodies Protect Against Ebola in Preclinical Studies Representing a Novel Platform for Antibody Therapies for Outbreak Infections 

Novel Mechanism of Immune Activation in HIV-exposed, Seronegative People who Inject Drugs

Our Centers

Ashani Weeraratna in lab

Cancer Center

Wistar is a National Cancer Institute Cancer Center in basic research and has held this designation since 1972.
Vials

Vaccine & Immunotherapy Center

Improving health around the globe by creating and advancing vaccines and immunotherapies.

Upcoming events

View all events ›

Wistar's Champion Run for Research 2018

Scientific Seminar

Philadelphia Drug Discovery Forum: Biacore User Day

Special Event

Nikon Small World Exhibition

125 Years of Discovery

View full timeline ›

Monoclonal Antibody Research

In 1979, Wistar scientists were among the first to develop and license antiviral and anti-tumor cell monoclonal antibodies and Wistar moved to the forefront of monoclonal antibody research.

View Full Timeline

Accelerating the future

Right now, Wistar Science is making discoveries that will advance human health.

Support Today